Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Agnosia × Epinephrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Thyroid Neoplasms 1 Stomach Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Lymphoma, Follicular 1 Goiter 1 Carcinoma, Renal Cell 1 Agnosia 1

Interventions

Sodium Chloride 2 Ropivacaine 2 Propofol 2 Ketamine 2 Analgesics, Opioid 2 Analgesia, Patient-Controlled 2 parecoxib 1 Tea 1 Tapentadol 1 Surveys and Questionnaires 1 Sevoflurane 1 Lidocaine 1 Ketorolac 1 Epinephrine 1 Dexamethasone 1 Clonidine 1 Celecoxib 1 Anesthesia, General 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡